Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis
Acta Ophthalmologica · 2024
DOI: 10.1111/aos.15681 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Dror Ben Ephraim Noyman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Eyelid Diseases, Meibomian Gland Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Purpose
To review the efficacy and safety of oral doxycycline antibiotics versus macrolides in the treatment of meibomian gland dysfunction (MGD).
Design
Systematic review and meta‐analysis.
Methods
We performed a systematic search of electronic databases for all peer‐reviewed published studies which included clinical outcomes of oral antibiotic MGD treatment. Individual study data were extracted and evaluated in a weighted pooled analysis, including total sign and symptom scores, meibomian gland secretion score, tear break‐up time (TBUT), fluorescein staining score and rate of complications.
Results
Two thousand nine hundred and thirty‐three studies were found, of which 54 were eligible for the systematic review, and six prospective studies were ultimately included for analysis, reporting on 563 cases from three countries. Age of affected patients ranged between 12 and 90 years. Overall, both treatment methods induced improvement in MGD signs and symptoms. In pooled analysis, macrolides were significantly superior in the total signs score (pooled standardized mean difference (SMD) −0.51, 95% confidence interval (CI): −0.99 to −0.03), meibomian gland secretion score (pooled SMD −0.25, 95%CI: [−0.48, −0.03]), TBUT (SMD −0.31, 95%CI: [−0.50, −0.13]) and fluorescein staining score (SMD −1.01, 95%CI: [−1.72, −0.29]). Moreover, while no severe complications were reported for both treatments, the macrolide group exhibited significantly less adverse events (pooled odds ratio 0.24 with a 95% CI of 0.16 to 0.34).
Conclusions
Both macrolides and tetracyclines are effective treatments for MGD. In this study, macrolides exhibited better efficacy and safety profile compared to tetracyclines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, Rambam Health Care Campus, Haifa, Israel.
- Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
- Ophthalmology Department, Yitzhak Shamir Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Michael Mimouni, Margarita Safir
Zitieren
APA
Ben Ephraim Noyman, D., Chan, C. C., Mimouni, M., & Safir, M. (2024). Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis. Acta Ophthalmologica. https://doi.org/10.1111/aos.15681
Vancouver
Ben Ephraim Noyman D, Chan CC, Mimouni M, Safir M. Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis. Acta Ophthalmologica. 2024. doi:10.1111/aos.15681
BibTeX
@article{BenEphraimNoyman2024,
author = {Ben Ephraim Noyman, Dror and Chan, Clara C and Mimouni, Michael and Safir, Margarita},
title = {Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis},
journal = {Acta Ophthalmologica},
year = {2024},
doi = {10.1111/aos.15681}
}
EUVIMED